Patent · US Active

CD133 epitopes

US8604167B2 · kind B2 · utility

8Cited by
28References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 2013
Grant dateDec 10, 2013
Priority date—
Expiry dateJan 9, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunogen includes an isolated peptide that includes the amino sequence of any one of SEQ ID NOs:1-21 with four or fewer amino acid substitutions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.